WS #2138

The Strait of Hormuz crisis remains the dominant market theme, with geopolitical tensions escalating as the U.S. intensifies military deployments and Trump criticizes NATO allies for insufficient support, corroborating earlier reports. New developments include a coalition of seven countries (UK, France, Germany, Italy, Netherlands, Japan, Canada) declaring readiness to unblock the strait, signaling a coordinated international response that could mitigate supply disruptions. However, this is offset by Iran's continued monetization of the blockade through fees for safe passage, as reports indicate shipping firms paying millions, complicating global logistics and sustaining energy supply fears. The IEA's warning of the 'greatest energy crisis in history' persists, with spillover effects like European gas price jumps noted previously, though no new data on this front emerges here. A significant counter-signal emerges from geopolitical maneuvering: Putin's offer to halt intelligence sharing with Iran if the U.S. cuts off Ukraine support, which the U.S. rejected, introduces a potential de-escalation lever but also heightens transatlantic tensions. This dampens bullish energy pressures by suggesting a possible diplomatic resolution, though its immediate impact is limited given the U.S. refusal. Concurrently, market implications broaden as the crisis revives rate hike concerns, with U.S. 2-year yields posting their biggest daily move since April 2025 and Polymarket pricing a 21% chance of a Fed hike, indicating shifting monetary policy expectations amid inflationary pressures from energy disruptions. In markets, price context shows minimal movement in major tech stocks (e.g., AAPL -0.03%, NVDA -0.01%) and broad indices (SPY +0.03%, QQQ +0.09%), reflecting cautious sentiment amid uncertainty. Recent prediction outcomes show mixed accuracy, with BABA down confirmed but XLE down and MU up refuted, highlighting volatility in energy and tech sectors. Other developments include legal actions (e.g., Trump suing Harvard over antisemitism) and analyst adjustments (e.g., Braze price target cut, Tyra Biosciences target raised), but these are secondary to the geopolitical and energy narrative.